Novo Nordisk is set to discontinue Levemir, a key long-acting insulin, by the end of 2024 due to manufacturing priorities and better alternatives, impacting supply and...
Affording Treatment
Diabetes care can be expensive, from daily supplies to glucose monitoring technology to medications to clinical care visits. The good news is there are a number of ways to afford treatment when living with diabetes, whether you are navigating a health insurance plan or paying out of pocket.
We bring you tips on saving money, navigating private insurance, workplace benefits, and Medicare, in addition to information about discounts on the drugs and devices that you use.
94 readers recommended
Ongoing hostilities and violence across the world leave people with diabetes in crisis and without access to essential resources. What can be done to help?
45 readers recommended
CMS initiates drug price negotiations, targeting diabetes drugs among others. Resulting from the Inflation Reduction Act, it aims for cost cuts by 2026, benefiting...
50 readers recommended
Amazon Pharmacy now auto-applies coupons to insulins and other diabetes supplies. See how you can save money and time.
87 readers recommended
Brenzavvy, an affordable FDA-approved Type 2 diabetes drug, now accessible via Cost Plus Drugs, aids in effective glucose management and diabetes control.
68 readers recommended
Learn about the importance of Ozempic – the new “miracle” diet drug that celebrities are using for weight loss – in diabetes care and weight loss while challenging...
55 readers recommended
At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...
49 readers recommended
A panel shared insights at the ADA’s 83rd Scientific Sessions on incorporating hypoglycemia as a quality measure in diabetes. Each expert noted the importance of...
63 readers recommended
UnitedHealthcare begins coverage for CGM in people with type 2 diabetes.
26 readers recommended
In a recent study, results showed that improved access to CGM can lower A1C levels in Hispanic children. However, broader societal strategies are needed to address...
245 readers recommended
On April 16, Medicare began covering people with type 2 diabetes for continuous glucose monitors (CGMs).
56 readers recommended
Following Eli Lilly’s recent announcement of a $35 monthly limit on out-of pocket costs, Sanofi announced a $35 cost cap on Lantus, and Novo Nordisk pledged to reduce...
125 readers recommended
Eli Lilly announced today that it will cut the list prices for its most commonly prescribed insulins, including Humalog and Humulin, by 70%. The drug maker will also...
49 readers recommended
Switching from private to public health insurance can be complicated – from the application process, to knowing your income eligibility, to dealing with negative stigma...
46 readers recommended
Starting in 2023, Delaware residents will not have to pay more than $35 per month for diabetes supplies and equipment such as glucose meters, continuous glucose monitors...
60 readers recommended
Continuous glucose monitoring coverage varies widely by state Medicaid program – check out our guide on who's covered and where
100 readers recommended
If you’ve got unused diabetes supplies that you no longer need, don’t throw them away! Here are several easy ways that you can donate your supplies to others.
68 readers recommended
Learn how you can get affordable insulin without insurance coverage
37 readers recommended
diaTribe writer and editor Jim Hirsch reviews an outstanding new PBS documentary that explores and gives new voices to the diabetes epidemic in the US
168 readers recommended
The recently passed Inflation Reduction Act includes new policies that cap the monthly cost of insulin at $35 and potentially reduce the cost of other diabetes drugs for...